AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00%

VLS Vita Life Sciences Limited

Healthcare · Drug Manufacturers - Specialty & Generic · website
$2.48
52wk 2.15 – 2.84
Overall
Value
Growth
Health
Quality
Momentum
Dividend
Price
About Vita Life Sciences Limited

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Mascot, Australia.

Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$134.84M
P/E (trailing)
13.78
P/E (forward)
EPS (trailing)
0.18
Dividend yield
5.7%
Payout ratio
60.0%
Beta
0.47
EV / EBITDA
7.02
Price / Book
2.45
ROE
19.2%
Operating margin
15.9%
Net margin
11.2%
Total cash
$35.56M
Total debt
$2.39M
Current ratio
2.73
Debt / Equity
0.04
Free cash flow
$14.36M
Avg volume
12,638
Latest annual results (FY ending 31 Dec 2025)
  • Revenue$93.27M
  • Gross profit$57.04M
  • Operating income$14.06M
  • Net income$10.44M
  • Diluted EPS0.18
  • Free cash flow$15.86M
  • Net debt-$33.17M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $59.53B 14.0
RMD $43.89B 20.4
SIG $34.28B 59.4
FPH $20.25B 52.2
PME $17.21B 73.5
SHL $10.79B 19.7
RHC $10.13B 34.8
COH $7.90B 22.9